Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
M2BPGi
Description:
M2BPGi is a serum glycoprotein biomarker used in clinical assessment of liver fibrosis and chronic liver disease.
Primary topic:
Liver Disease Diagnosis and Treatment (43%)
Related topics:
Liver Disease Diagnosis and Treatment (43%),
Hepatocellular Carcinoma Treatment and Prognosis (11%),
Hepatitis C virus research (9%)
OpenAlex ID:
keywords/m2bpgi
Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis
2018
·
Ken Shirabe
, Yuki Bekki
, et al.
·
Journal of Gastroenterology
·
192
Novel biomarkers for the management of chronic hepatitis B
2020
·
Takako Inoue
, Yasuhito Tanaka
·
Clinical and Molecular Hepatology
·
131
PDF
Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
2023
·
Chih-Lin Lin
, Jia-Horng Kao
·
Clinical and Molecular Hepatology
·
104
PDF
Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus
2020
·
Naoki Matsuoka
, Yuya Fujita
, et al.
·
PLoS ONE
·
75
PDF
Development of M2BPGi: a novel fibrosis serum glyco-biomarker for chronic hepatitis/cirrhosis diagnostics
2015
·
Hisashi Narimatsu
·
Expert Review of Proteomics
·
67
Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy
2016
·
The Ochanomizu Liver Conference Study Group
, Hiroko Nagata
, et al.
·
Hepatology International
·
65
Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver Diseases
2020
·
Nobuharu Tamaki
, Masayuki Kurosaki
, et al.
·
Annals of Laboratory Medicine
·
54
Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia
2016
·
Naoya Yamada
, Yukihiro Sanada
, et al.
·
Journal of Gastroenterology
·
52
Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C
2017
·
Hongqin Xu
, Wenli Kong
, et al.
·
BMC Gastroenterology
·
49
PDF
Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi
2020
·
Ian Baudi
, Takako Inoue
, et al.
·
International Journal of Molecular Sciences
·
48
PDF
Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group
2018
·
Keiji Tsuji
, Masayuki Kurosaki
, et al.
·
Journal of Gastroenterology
·
46
Mac‐2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection
2019
·
Tomi Jun
, Yao‐Chun Hsu
, et al.
·
Hepatology Communications
·
44
PDF
Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection
2018
·
Lung-Yi Mak
, Danny Ka-Ho Wong
, et al.
·
Clinical and Translational Gastroenterology
·
43
Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C
2018
·
Kentaro Matsuura
, Nobuhiro Aizawa
, et al.
·
Open Forum Infectious Diseases
·
41
PDF
Pemafibrate improves hepatic inflammation, function and fibrosis in patients with non-alcoholic fatty liver disease: a one-year observational study
2021
·
Satoshi Shinozaki
, Toshiyuki Tahara
, et al.
·
Clinical and Experimental Hepatology
·
40
PDF
High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analogues
2017
·
Noboru Shinkai
, Masanori Nojima
, et al.
·
Journal of Gastroenterology
·
40
Usefulness of Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, and Soluble Suppression of Tumorigenicity 2 for Assessing Liver Fibrosis in Chronic Liver Diseases
2018
·
Hee-Won Moon
, Mikyoung Park
, et al.
·
Annals of Laboratory Medicine
·
39
PDF
Serum Levels of M2BPGi as Short-Term Predictors of Hepatocellular Carcinoma in Untreated Chronic Hepatitis B Patients
2017
·
Jessica Liu
, Hui-Han Hu
, et al.
·
Scientific Reports
·
39
PDF
Usefulness of Mac-2 Binding Protein Glycosylation Isomer for Prediction of Posthepatectomy Liver Failure in Patients With Hepatocellular Carcinoma
2016
·
Yukihiro Okuda
, Kojiro Taura
, et al.
·
Annals of Surgery
·
39
PDF
Mac-2-binding protein glycan isomer enhances the aggressiveness of hepatocellular carcinoma by activating mTOR signaling
2020
·
Gantumur Dolgormaa
, Norifumi Harimoto
, et al.
·
British Journal of Cancer
·
37
PDF
Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases
2020
·
Se Young Jang
, Won Young Tak
, et al.
·
Annals of Laboratory Medicine
·
36
Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti‐viral therapy in patients with chronic hepatitis B
2018
·
Yao‐Chun Hsu
, Tomi Jun
, et al.
·
Alimentary Pharmacology & Therapeutics
·
34
Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B
2020
·
Yuki Tsuji
, Tadashi Namisaki
, et al.
·
Experimental and Therapeutic Medicine
·
33
PDF
Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury
2017
·
Kei Morio
, Michio Imamura
, et al.
·
Journal of Gastroenterology
·
33
Progress in Biomarkers Related to Biliary Atresia
2024
·
Fanyang Kong
, Rui Dong
, et al.
·
Journal of Clinical and Translational Hepatology
·
32
PDF
Show more works
View as search
Works count:
389
Citation count:
3,134
Year
Topic
Type